Africa News Line Saturday, 12.21.2024, 6:46 PM
Welcome Guest | RSS
Site menu

Main » 2024 » December » 17

WILMINGTON, Del. -

(BUSINESS WIRE)--CSC, the world’s leading provider of global business administration and compliance solutions, is pleased to announce the expansion of its newly combined Funds and Capital Markets (FCM) division, with the strategic appointments of John Hebert and Venkat Srinivasan.

The move follows CSC’s announcement earlier this year that the Intertrust Group acquisition of November 2022 had been fully integrated and migrated to the CSC brand. CSC delivers unmatched client service, market-leading expertise, and global solutions consistently, through more than 8,000 dedicated employees, and with capabilities across more than 140 jurisdictions.

By combining CSC’s existing Funds and Capital Markets businesses, which span five continents and a team of several thousand experts, the integration and new leadership will facilitate accelerated growth plans and enable a comprehensive and tailored service offering for fund managers, ... Read more »

Views: 15 | Added by: africa-live | Date: 12.17.2024 | Comments (0)

Abu Dhabi/Dubai, United Arab Emirates, 16 December 2024:

 

ONE Development ... Read more »

Views: 25 | Added by: africa-live | Date: 12.17.2024

BEIJING - Monday, 16. December 2024

The first phase III clinical trial on a multivalent HFMD vaccine in the world

(BUSINESS WIRE) -- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus 71 (EV71) and Coxsackievirus 16 (CA16). Notably, no multivalent vaccines against HFMD have yet been approved for marketing worldwide.

The Phase III clinical trial is designed to be a multicenter, randomized, double-blind, controlled trial to evaluate the efficacy, safety and immunogenicity of this vaccine candidate in infants and young children aged 6 to 71 months.

SINOVAC has initiated a phase I/II clinical trial on its bivalent vaccine in China since September 2023. The results from Phase I/II clinical trial demonstrated that the vaccine candidate ... Read more »

Views: 12 | Added by: africa-live | Date: 12.17.2024 | Comments (0)

GREENWICH, Conn. - Monday, 16. December 2024 AETOSWire Print 


Combining Streamlined Design with Powerful Trading Technology

 

(BUSINESS WIRE)--Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced updates to IBKR Desktop, a modern trading platform for investors who demand simplicity but value Interactive Brokers’ advanced technology. With no platform fees and a user-friendly interface packed with advanced features, clients can easily facilitate simple trades across asset classes and complex order types. Suitable for both experienced traders and novice investors, IBKR Desktop offers superior order execution, competitive pricing and an extensive suite of global investment products designed to optimize trading and enhance investment strategies.

With IBKR Desktop, clients can trade stocks, options, futures, currencies, bonds, and funds on over ... Read more »

Views: 14 | Added by: africanewsline | Date: 12.17.2024 | Comments (0)

The human microbiota pioneer invests in an agile and transparent supply chain to better meet patient needs

(BUSINESS WIRE) -- Biocodex, a pioneer and leader in human microbiota health, as well as an innovator in pharmaceuticals, has partnered with Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, to modernize and optimize its processes. Through this collaboration, Biocodex aims to achieve greater forecast accuracy, simplify the management of regulatory challenges, and enhance resilience against disruptions.

Biocodex is a French, family-owned, pharmaceutical company that has grown from microbiota pioneer to an international leader with its diverse portfolio focused on three areas of expertise: microbiota care, women’s health and orphan diseases. The pharmaceutical company serves patients in more than 100 countries with its three industrial facilities in France and Morocco, and R&D center also located in France.

& ... Read more »

Views: 14 | Added by: africa-live | Date: 12.17.2024 | Comments (0)

LOS ANGELES - Thursday, 12. December 2024 AETOSWire 

High-Octane Parkour Challenges Meet Story-Driven Gameplay in a New Fortnite Creative Map Inspired by Once Upon Tomorrow

 

(BUSINESS WIRE)--Shurick Agapitov, founder of Xsolla and visionary in the gaming industry, proudly announces the Once Upon Tomorrow Fortnite Island release. This immersive Fortnite Creative map transports players into the rich narrative world of his novel. The innovative experience, developed in Unreal Editor for Fortnite (UEFN), masterfully combines high-speed parkour challenges with deep thematic elements from Once Upon Tomorrow, inviting players to test their skills while journeying through a visually captivating landscape that embodies the resilience and adventure of the book’s characters.

“Once Upon Tomorrow in Fortnite Creative is our way of expanding the reach and depth of the novel, offering players an interactive journey that challenges both their s ... Read more »

Views: 19 | Added by: africa-live | Date: 12.17.2024 | Comments (0)

Search

Entries archive

Calendar
«  December 2024  »
SuMoTuWeThFrSa
1234567
891011121314
15161718192021
22232425262728
293031